Depending on federal and state requirements, pharmaceutical, medical device, and biologics companies may be required to report payments and transfers of value (“spend”) to healthcare professionals, healthcare facilities, and teaching hospitals. QPharma provides industry-leading consulting and technology solutions to help life sciences companies comply.
Tracking and Reporting with Ti Spend®
Depending on federal and state requirements, pharmaceutical, medical device, and biologics companies may be required to report payments and transfers of value (“spend”) to healthcare professionals, healthcare facilities, and teaching hospitals. Ti Spend®, part of the Titanium® platform, collects and compiles spend data according to each regulation and generates federal and state reports clients can file with confidence. The configurable system can link customer data from multiple sources, and it incorporates diverse methods for reviewing a data feed and identifying missing or malformed fields during data upload. QPharma's Titanium® platform matches and validates recipients to CMS, NPPES and state databases to ensure all reportable recipients are appropriately identified. QPharma’s experts serve as data submitters wherever possible, and provide ongoing support for data submissions, disputes, and remediation.
State transparency regulations include requirements for specific mandates in a manufacturer’s Compliance Program and Code of Conduct, as well as gift bans and spend limits. QPharma’s team of in-house compliance experts help clients ensure they remain compliant with all the individual requirements, even when there are no reporting requirements. QPharma experts stay current on the latest regulatory developments by state, region, and city and provide clients with regulatory alerts as part of QPharma standard transparency services. Hourly and retainer-based consulting services are also available to assist clients with specific issues or concerns
Compliant Reporting with Ti Sample Transparency®
Life sciences companies are required to file annual drug and device sample disbursement reports to the FDA and the states of Vermont and Nevada. Each of the federal and state regulations differs in the definition of a sample and how the distributions are reported. QPharma’s Ti Sample Transparency® reporting solution tracks all sample distribution data in a secure database, applies the appropriate reporting requirements, and provides correctly formatted, compliant annual reports with ease.
Transparency Compliance Consulting
State transparency regulations include requirements for specific mandates in a manufacturer’s Compliance Program and Code of Conduct, as well as gift bans and spend limits. QPharma’s team of in-house compliance experts help clients ensure they remain compliant with all the individual requirements, even when there are no reporting requirements. QPharma experts stay current on the latest regulatory developments by state, region, and city and provide clients with regulatory alerts as part of QPharma standard transparency services. Hourly and retainer-based consulting services are also available to help clients with specific issues or concerns.
Whatever your Spend/Transparency solution needs may be, QPharma has the solution.
Contact us today.
